Old Web
English
Sign In
Acemap
>
authorDetail
>
Vyankatesh K Shivane
Vyankatesh K Shivane
Internal medicine
Medicine
Diabetes mellitus
Type 2 diabetes
Type 2 Diabetes Mellitus
4
Papers
10
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Multicentre, Multinational, Open-Label, 52-Week Extension Study of Gemigliptin (LC15-0444) Monotherapy in Patients with Type 2 Diabetes Mellitus.
2020
Diabetes & Metabolism Journal
Sae Jeong Yang
Kyung Wan Min
Sandeep Kumar Gupta
Joong-Yeol Park
Vyankatesh K Shivane
Pankaj Kumar Agarwal
Doo-Man Kim
Yong Esong Kim
Sei Hyun Baik
Show All
Source
Cite
Save
Citations (0)
592-P: Diabetic Retinopathy Grade as Predictor of Outcomes in Patients with Type 2 Diabetes and Lower Extremity Amputations—Multicentric Longitudinal Seven-Year Study
2019
Diabetes
Kiran Shah
Sundaram Natarajan
Vishwanath Parsewar
Vyankatesh K Shivane
Show All
Source
Cite
Save
Citations (0)
Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial
2018
Journal of Diabetes Investigation
Ronald Cw Ma
Stefano Del Prato
Baptist Gallwitz
Vyankatesh K Shivane
Diane J. Lewis-D'Agostino
Zelie Bailes
Sanjay Patel
Jisoo Lee
Maximilian von Eynatten
Maximiliano di Domenico
Stuart A. Ross
Show All
Source
Cite
Save
Citations (8)
A 52‐week extension study of switching from gemigliptin vs sitagliptin to gemigliptin only as add‐on therapy for patients with type 2 diabetes who are inadequately controlled with metformin alone
2018
Diabetes, Obesity and Metabolism
Chan-Hee Jung
Eun-Jung Rhee
Won-Young Lee
Kyung Wan Min
Vyankatesh K Shivane
Aravind R. Sosale
Hak Chul Jang
Choon Hee Chung
Il Seong Nam-Goong
Show All
Source
Cite
Save
Citations (2)
1